Hematopoietic Stem Cells in Type 1 Diabetes

Hematopoietic Stem Cells in Type 1 Diabetes

Despite the increasing knowledge of pathophysiological mechanisms underlying the onset of type 1 diabetes (T1D), the quest for therapeutic options capable of delaying/reverting the diseases is still ongoing. Among all strategies currently tested in T1D, the use of hematopoietic stem cell (HSC)-based...

Full description

Bibliographic Details
Main Authors: Ida Pastore, Emma Assi, Moufida Ben Nasr, Andrea Mario Bolla, Anna Maestroni, Vera Usuelli, Cristian Loretelli, Andy Joe Seelam, Ahmed Abdelsalam, Gian Vincenzo Zuccotti, Francesca D’Addio, Paolo Fiorina
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Immunology
Subjects:
type 1 diabetes
hematopoietic stem cells
autoimmune response
NOD mouse model
genetic modulation
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.694118/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.694118/full

Similar Items